Mail

UK markets closed

FTSE 100
7,389.98
+87.24(+1.19%)
FTSE 250
19,835.95
+146.93(+0.75%)
AIM
956.64
+9.47(+1.00%)
GBP/EUR
1.1822
+0.0040(+0.34%)
GBP/USD
1.2495
+0.0020(+0.16%)
BTC-GBP
23,555.54
+289.48(+1.24%)

Eight new homes for first-time buyers

Here’s a round-up of some of the best houses available via schemes that offer some form of help for first-time buyers

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK

Add to watchlist

761.30

+30.40

(+4.16%)

At close: 04:59PM CEST

Currency in DKK

Earnings estimate	Current qtr. (Jun 2022)	Next qtr. (Sep 2022)	Current year (2022)	Next year (2023)
No. of analysts	9	9	29	29
Avg. Estimate	5.74	5.89	23.45	28.19
Low estimate	5.37	5.35	21.49	24.7
High estimate	6.35	6.28	29.4	33.1
Year ago EPS	5.26	5.27	20.74	23.45

Revenue estimate	Current qtr. (Jun 2022)	Next qtr. (Sep 2022)	Current year (2022)	Next year (2023)
No. of analysts	10	10	29	29
Avg. Estimate	39.86B	41.6B	165.76B	186.67B
Low estimate	36.53B	38.85B	150.46B	167.11B
High estimate	42.2B	43.46B	186.02B	205.95B
Year ago sales	N/A	35.62B	140.8B	165.76B
Sales growth (year/est)	N/A	16.80%	17.70%	12.60%

Earnings history	30/06/2021	30/09/2021	31/12/2021	31/03/2022
Est. EPS	4.77	5	4.7	5.7
Actual EPS	5.26	5.27	4.76	6.22
Difference	0.49	0.27	0.06	0.52
Surprise %	10.30%	5.40%	1.30%	9.10%

EPS trend	Current qtr. (Jun 2022)	Next qtr. (Sep 2022)	Current year (2022)	Next year (2023)
Current estimate	5.74	5.89	23.45	28.19
7 days ago	5.75	5.88	23.38	28.07
30 days ago	5.52	5.66	22.76	26.95
60 days ago	5.5	5.68	22.63	26.74
90 days ago	5.4	5.65	22.58	26.44

EPS revisions	Current qtr. (Jun 2022)	Next qtr. (Sep 2022)	Current year (2022)	Next year (2023)
Up last 7 days	N/A	1	2	2
Up last 30 days	4	6	17	18
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	1	N/A	N/A	N/A

Growth estimates	NOVO-B.CO	Industry	Sector(s)	S&P 500
Current qtr.	9.10%	N/A	N/A	N/A
Next qtr.	11.80%	N/A	N/A	N/A
Current year	13.10%	N/A	N/A	N/A
Next year	20.20%	N/A	N/A	N/A
Next 5 years (per annum)	16.54%	N/A	N/A	N/A
Past 5 years (per annum)	7.62%	N/A	N/A	N/A